BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND PALB2, ENSG00000083093, 79728
48 results:

  • 1. Genomic Profiling Reveals germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar cell Carcinoma.
    Mandelker D; Marra A; Zheng-Lin B; Selenica P; Blanco-Heredia J; Zhu Y; Gazzo A; Wong D; Yelskaya Z; Rai V; Somar J; Ostafi S; Mehta N; Yang C; Li Y; Brown DN; da Silva EM; Pei X; Linkov I; Terraf P; Misyura M; Ceyhan-Birsoy O; Ladanyi M; Berger M; Pareja F; Stadler Z; Offit K; Riaz N; Park W; Chou J; Capanu M; Koehler M; Rosen E; O'Reilly EM; Reis-Filho JS
    J Clin Oncol; 2023 Nov; 41(33):5151-5162. PubMed ID: 37607324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
    Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
    Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rare germline variants in palb2 and BRCA2 in familial and sporadic chordoma.
    Xia B; Biswas K; Foo TK; Gomes TT; Riedel-Topper M; Southon E; Kang Z; Huo Y; Reid S; Stauffer S; Zhou W; Zhu B; Koka H; Yepes S; Brodie SA; Jones K; Vogt A; Zhu B; Carter B; Freedman ND; Hicks B; Yeager M; Chanock SJ; Couch F; Parry DM; Monteiro AN; Goldstein AM; Carvalho MA; Sharan SK; Yang XR
    Hum Mutat; 2022 Oct; 43(10):1396-1407. PubMed ID: 35762214
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization of rare histological subtypes of ovarian cancer based on molecular profiling.
    Takahashi N; Hatakeyama K; Nagashima T; Ohshima K; Urakami K; Yamaguchi K; Hirashima Y
    Cancer Med; 2023 Jan; 12(1):387-395. PubMed ID: 35676859
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity.
    Fang Y; Wang YZ; Wei X; Li SM; Chen L
    Fetal Pediatr Pathol; 2023 Feb; 42(1):114-122. PubMed ID: 35404193
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and palb2 in a tumor-Only Genomic Testing Program.
    Bychkovsky BL; Li T; Sotelo J; Tayob N; Mercado J; Gomy I; Chittenden A; Kane S; Stokes S; Hughes ME; Kim JS; Umeton R; Awad MM; Konstantinopoulos PA; Yurgelun MB; Wolpin BM; Taplin ME; Newmark RE; Johnson BE; Lindeman NI; MacConaill LE; Garber JE; Lin NU
    Clin Cancer Res; 2022 Jun; 28(11):2349-2360. PubMed ID: 35363308
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. germline breast cancer susceptibility genes, tumor characteristics, and survival.
    Ho PJ; Khng AJ; Loh HW; Ho WK; Yip CH; Mohd-Taib NA; Tan VKM; Tan BK; Tan SM; Tan EY; Lim SH; Jamaris S; Sim Y; Wong FY; Ngeow J; Lim EH; Tai MC; Wijaya EA; Lee SC; Chan CW; Buhari SA; Chan PMY; Chen JJC; Seah JCM; Lee WP; Mok CW; Lim GH; Woo E; Kim SW; Lee JW; Lee MH; Park SK; Dunning AM; Easton DF; Schmidt MK; Teo SH; Li J; Hartman M
    Genome Med; 2021 Dec; 13(1):185. PubMed ID: 34857041
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutational landscape in Uveal Melanoma.
    Mastronikolis S; Adamopoulou M; Papouliakos S; Manoli A; Katsinis S; Makri O; Monastirioti AE; Tsiambas E; Georgakopoulos C
    J BUON; 2021; 26(4):1194-1197. PubMed ID: 34564968
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. germline mutations in a DNA repair pathway are associated with familial colorectal cancer.
    Xu P; Sun D; Gao Y; Jiang Y; Zhong M; Zhao G; Chen J; Wang Z; Liu Q; Hong J; Chen H; Chen YX; Fang JY
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549727
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A rare palb2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy.
    Beer A; Beck R; Schedel A; von Bonin M; Meinel J; Friedrich UA; Menzel M; Suttorp M; Brenner S; Fitze G; Lange B; Knöfler R; Hauer J; Auer F
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1746. PubMed ID: 34382369
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Therapeutic Implications of germline Testing in Patients With Advanced Cancers.
    Stadler ZK; Maio A; Chakravarty D; Kemel Y; Sheehan M; Salo-Mullen E; Tkachuk K; Fong CJ; Nguyen B; Erakky A; Cadoo K; Liu Y; Carlo MI; Latham A; Zhang H; Kundra R; Smith S; Galle J; Aghajanian C; Abu-Rustum N; Varghese A; O'Reilly EM; Morris M; Abida W; Walsh M; Drilon A; Jayakumaran G; Zehir A; Ladanyi M; Ceyhan-Birsoy O; Solit DB; Schultz N; Berger MF; Mandelker D; Diaz LA; Offit K; Robson ME
    J Clin Oncol; 2021 Aug; 39(24):2698-2709. PubMed ID: 34133209
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
    Vietri MT; D'Elia G; Caliendo G; Resse M; Casamassimi A; Passariello L; Albanese L; Cioffi M; Molinari AM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916521
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.
    Lobo J; Constâncio V; Guimarães-Teixeira C; Leite-Silva P; Miranda-Gonçalves V; Sequeira JP; Pistoni L; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
    Mol Oncol; 2021 Apr; 15(4):846-865. PubMed ID: 33513287
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pancreatic Gastrinoma, Gastrointestinal Stromal tumor (GIST), Pheochromocytoma, and Hürthle cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.
    Arif AA; Kim PTW; Melck A; Churg A; Schwartz Z; Stuart HC
    Am J Case Rep; 2021 Jan; 22():e927761. PubMed ID: 33452231
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Atypical choroidal nevus in a subject with a germline palb2 pathogenic variant.
    Grosel TW; Karl M; Pilarski RT; Davidorf FH; Abdel-Rahman MH; Cebulla CM
    Fam Cancer; 2022 Jan; 21(1):1-5. PubMed ID: 33403473
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors.
    Han J; Yu M; Bai Y; Yu J; Jin F; Li C; Zeng R; Peng J; Li A; Song X; Li H; Wu D; Li L
    Cancer Cell; 2020 Dec; 38(6):844-856.e7. PubMed ID: 33186520
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Successful BRAF/MEK inhibition in a patient with
    Busch E; Kreutzfeldt S; Agaimy A; Mechtersheimer G; Horak P; Brors B; Hutter B; Fröhlich M; Uhrig S; Mayer P; Schröck E; Stenzinger A; Glimm H; Jäger D; Springfeld C; Fröhling S; Zschäbitz S
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843432
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A germline
    Zhong Y; Schubert J; Wu J; Xu F; Lin F; Cao K; Zelley K; Luo M; Foster JB; Cole KA; MacFarland SP; Resnick AC; Storm PB; Li MM
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32554798
    [No Abstract]    [Full Text] [Related]  

  • 19. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A genome-wide association study on medulloblastoma.
    Dahlin AM; Wibom C; Andersson U; Bybjerg-Grauholm J; Deltour I; Hougaard DM; Scheurer ME; Lau CC; McKean-Cowdin R; Kennedy RJ; Hung LT; Yee J; Margol AS; Barrington-Trimis J; Gauderman WJ; Feychting M; Schüz J; Röösli M; Kjaerheim K; ; Januszkiewicz-Lewandowska D; Fichna M; Nowak J; Searles Nielsen S; Asgharzadeh S; Mirabello L; Hjalmars U; Melin B
    J Neurooncol; 2020 Apr; 147(2):309-315. PubMed ID: 32056145
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.